Page last updated: 2024-11-01

ondansetron and Diabetic Neuropathies

ondansetron has been researched along with Diabetic Neuropathies in 2 studies

Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.

Diabetic Neuropathies: Peripheral, autonomic, and cranial nerve disorders that are associated with DIABETES MELLITUS. These conditions usually result from diabetic microvascular injury involving small blood vessels that supply nerves (VASA NERVORUM). Relatively common conditions which may be associated with diabetic neuropathy include third nerve palsy (see OCULOMOTOR NERVE DISEASES); MONONEUROPATHY; mononeuropathy multiplex; diabetic amyotrophy; a painful POLYNEUROPATHY; autonomic neuropathy; and thoracoabdominal neuropathy. (From Adams et al., Principles of Neurology, 6th ed, p1325)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bektas, N1
Arslan, R1
Ozturk, Y1
Bossi, A1
Baresi, A1
Ballini, A1
Bindelli, C1

Other Studies

2 other studies available for ondansetron and Diabetic Neuropathies

ArticleYear
Zonisamide: Antihyperalgesic efficacy, the role of serotonergic receptors on efficacy in a rat model for painful diabetic neuropathy.
    Life sciences, 2014, Jan-24, Volume: 95, Issue:1

    Topics: Animals; Anticonvulsants; Carbamazepine; Diabetic Neuropathies; Disease Models, Animal; Dose-Respons

2014
Ondasentron in the treatment of diabetic diarrhea.
    Diabetes care, 1994, Volume: 17, Issue:5

    Topics: Diabetes Mellitus, Type 1; Diabetic Neuropathies; Diarrhea; Glycated Hemoglobin; Humans; Male; Middl

1994